Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2006 3
2007 1
2008 5
2009 6
2010 1
2011 3
2012 8
2013 16
2014 11
2015 8
2016 9
2017 12
2018 20
2019 14
2020 13
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

125 results
Results by year
Filters applied: . Clear all
Page 1
Targeted therapies in pulmonary arterial hypertension.
Montani D, Chaumais MC, Guignabert C, Günther S, Girerd B, Jaïs X, Algalarrondo V, Price LC, Savale L, Sitbon O, Simonneau G, Humbert M. Montani D, et al. Among authors: guignabert c. Pharmacol Ther. 2014 Feb;141(2):172-91. doi: 10.1016/j.pharmthera.2013.10.002. Epub 2013 Oct 14. Pharmacol Ther. 2014. PMID: 24134901 Free article. Review.
[New insights in the pathogenesis of pulmonary arterial hypertension].
Bordenave J, Tu L, Savale L, Huertas A, Humbert M, Guignabert C. Bordenave J, et al. Among authors: guignabert c. Rev Mal Respir. 2019 Apr;36(4):433-437. doi: 10.1016/j.rmr.2019.03.003. Epub 2019 Apr 19. Rev Mal Respir. 2019. PMID: 31010759 Free article. Review. French.
Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension.
Tu L, Desroches-Castan A, Mallet C, Guyon L, Cumont A, Phan C, Robert F, Thuillet R, Bordenave J, Sekine A, Huertas A, Ritvos O, Savale L, Feige JJ, Humbert M, Bailly S, Guignabert C. Tu L, et al. Among authors: guignabert c. Circ Res. 2019 Mar 15;124(6):846-855. doi: 10.1161/CIRCRESAHA.118.313356. Circ Res. 2019. PMID: 30636542 Free article.
Pulmonary complications of Bcr-Abl tyrosine kinase inhibitors.
Weatherald J, Bondeelle L, Chaumais MC, Guignabert C, Savale L, Jaïs X, Sitbon O, Rousselot P, Humbert M, Bergeron A, Montani D. Weatherald J, et al. Among authors: guignabert c. Eur Respir J. 2020 Oct 29;56(4):2000279. doi: 10.1183/13993003.00279-2020. Print 2020 Oct. Eur Respir J. 2020. PMID: 32527740 Review.
Relevant issues in the pathology and pathobiology of pulmonary hypertension.
Tuder RM, Archer SL, Dorfmüller P, Erzurum SC, Guignabert C, Michelakis E, Rabinovitch M, Schermuly R, Stenmark KR, Morrell NW. Tuder RM, et al. Among authors: guignabert c. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D4-12. doi: 10.1016/j.jacc.2013.10.025. J Am Coll Cardiol. 2013. PMID: 24355640 Free PMC article. Review.
PPARγ Interaction with UBR5/ATMIN Promotes DNA Repair to Maintain Endothelial Homeostasis.
Li CG, Mahon C, Sweeney NM, Verschueren E, Kantamani V, Li D, Hennigs JK, Marciano DP, Diebold I, Abu-Halawa O, Elliott M, Sa S, Guo F, Wang L, Cao A, Guignabert C, Sollier J, Nickel NP, Kaschwich M, Cimprich KA, Rabinovitch M. Li CG, et al. Among authors: guignabert c. Cell Rep. 2019 Jan 29;26(5):1333-1343.e7. doi: 10.1016/j.celrep.2019.01.013. Cell Rep. 2019. PMID: 30699358 Free PMC article.
Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension.
Guignabert C, Phan C, Seferian A, Huertas A, Tu L, Thuillet R, Sattler C, Le Hiress M, Tamura Y, Jutant EM, Chaumais MC, Bouchet S, Manéglier B, Molimard M, Rousselot P, Sitbon O, Simonneau G, Montani D, Humbert M. Guignabert C, et al. J Clin Invest. 2016 Sep 1;126(9):3207-18. doi: 10.1172/JCI86249. Epub 2016 Aug 2. J Clin Invest. 2016. PMID: 27482885 Free PMC article. Clinical Trial.
125 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page